At AIPCon 8, Birgit Schoeberl, Head of Data42 at Novartis, provides a rare showing of Palantir’s work in commercial pharmaceuticals. Through the comprehensive Ontology, with tens of billions of rows of data from 3000 clinical trials with more than 1M patients — a future of agentic R&D is accelerating drug discovery.